Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 20: 305-306, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walberg, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walberg, C. B.

Clinical Chemistry, Vol 20, 305-306, Copyright © 1974 by the American Association for Clinical Chemistry

Correlation of the "EMIT" Urine Barbiturate Assay with a Spectrophotometric Serum Barbiturate Assay in Suspected Overdose

Clifford B. Walberg 1

1 Section of Laboratories and Pathology, Los Angeles County-University of Southern California Medical Center, 1200 N. State St.; Los Angeles, Calif. 90033.

A rapid method for determining the presence of barbiturate in serum has been needed for some time. Presently used methods are all relatively time-consuming. A rapid immunoassay for the detection of barbiturate in urine, the "Enzyme Multiplied Immunoassay Technique" (EMIT), has recently become available. We have compared results of the EMIT urine assay with results of a spectrophotometric assay of serum (203 patients). Our purpose was: (a) to determine whether a negative result would be obtained with the EMIT assay in cases in which barbiturate was not a factor in coma, and (b) to determine whether a positive EMIT result would be obtained when a significant (3 mg/liter) quantity of barbiturate was in fact present in the serum. We conclude that the EMIT urine assay suffices to indicate clinically if barbiturate may be responsible if a patient is comatose. Results for a specimen (i.e., positive or negative) can be obtained in 5-10 min, so time saved by using the EMIT urine assay as a screening technique is significant.


Key Words: screening • drug abuse • toxicology

Submitted on November 5, 1973
Accepted on November 14, 1973






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.